Unrelated bone marrow transplant. Use of IL2 receptor monoclonal antibody (IL2-R-Ab) in prophylaxis of GVHD. The GEGMO Group.
Belanger
C
C
Esperou-Bourdeau
H
H
Raffoux
C
C
Gluckman
E
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology / Q000401:mortality; D005602:France / Q000453:epidemiology; D006086:Graft vs Host Disease / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D006648:Histocompatibility; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016019:Survival Analysis; D014019:Tissue Donors
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D015375:Receptors, Interleukin-2